Skip to main content
. 2022 Sep 27;13:1005522. doi: 10.3389/fgene.2022.1005522

FIGURE 2.

FIGURE 2

Overview of the role of H19 in modulating breast cancer therapy resistance. H19 related pathways in BC endocrine therapy resistance; H19 related pathways in BC chemotherapy resistance; H19 related pathways in BC targeted therapy resistance (BC, breast cancer).